BREAKING
Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 8 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 8 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 8 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 8 hours ago CMCT Reports Q4 Loss of $11.20/Share 8 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 9 hours ago BREAKING: KFY Reports Q3 Earnings 9 hours ago Vicor (VICR) reported Q4 2025 diluted EPS of $1.01 9 hours ago FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop 11 hours ago BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected 11 hours ago Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 8 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 8 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 8 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 8 hours ago CMCT Reports Q4 Loss of $11.20/Share 8 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 9 hours ago BREAKING: KFY Reports Q3 Earnings 9 hours ago Vicor (VICR) reported Q4 2025 diluted EPS of $1.01 9 hours ago FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop 11 hours ago BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected 11 hours ago
ADVERTISEMENT
Analysis

CEVA, Inc. Reports Sequential Revenue Growth Ahead of Q4 2025 Earnings Release

$CEVA February 17, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$CEVA · Earnings

CEVA, Inc.

Staff Correspondent · February 17, 2026

Current Status Overview

CEVA, Inc. (NASDAQ: CEVA) is a semiconductor intellectual property licensor specializing in wireless connectivity and smart edge technologies. The company is scheduled to report fourth quarter and full year 2025 financial results before market open on February 17, 2026. Recent quarterly performance reflects sequential revenue improvement. Operating income remains constrained amid continued investment in research and development. Licensing and royalty revenues continue to represent core revenue streams.

Share Price Performance

CEVA shares recently traded in the low-to-mid $20 range ahead of earnings. Recent trading activity reflects limited volatility. The stock has experienced moderate fluctuations over the past several months. Market capitalization remains consistent with small-cap semiconductor IP peers. Investors are awaiting updated financial guidance.

Revenue Performance

Revenue for Q1 2025 totaled $24.2 million. Revenue for Q2 2025 totaled $25.7 million. Revenue for Q3 2025 totaled $28.4 million. Three-month revenue stands at $28.4 million. Six-month revenue totals $54.1 million and nine-month revenue totals $78.3 million.

Market Analysis

CEVA operates within the semiconductor intellectual property licensing sector. The company competes with other IP providers focused on connectivity and AI processing architectures. Industry demand is influenced by trends in artificial intelligence, edge computing, and wireless standards evolution. Competitive pressure remains present in pricing and licensing structures. Overall sector conditions remain stable.

Analyst Commentary

Analyst coverage reflects mixed ratings with varying price targets. Consensus estimates project moderate revenue growth over upcoming periods. Earnings expectations remain subject to updated company guidance. Views differ regarding valuation relative to sector peers. No material consensus revision has been reported ahead of earnings.

ADVERTISEMENT

Mergers & Acquisitions

None reported.

Outlook

The company’s outlook remains pending release of fourth quarter 2025 financial results. Forward guidance has not yet been updated. Market participants are focused on revenue trajectory and margin performance. Future performance will depend on licensing activity and royalty growth. Near-term visibility remains limited until earnings disclosure.

ADVERTISEMENT